emerging immunotherapy beyond checkpoint inhibitors for tnbc
Published 1 year ago • 164 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
0:53
strategies to enhance anti-tumor t cell response to immune checkpoint inhibitors in tnbc
-
0:57
strategies for patients with tnbc progressing on checkpoint inhibitors
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
7:09
personalizing immunotherapy beyond pdl1 expression
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
5:33
cancer immune checkpoint inhibitors
-
15:51
introduction to immunotherapy (immunotherapy documentary part i)
-
1:01:54
"immune checkpoint blockade in cancer therapy" by dr. jim allison
-
1:00:44
targeting cancer pathways: understanding immune checkpoints
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
2:07
the association between jnk activity and immunotherapeutic efficacy of io in tnbc
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
5:10
introduction to immune checkpoint inhibitor (ici) immunotherapy
-
1:15
clinical implications of progress in tnbc therapies
-
58:04
beyond checkpoint blockade for cancer immunotherapy
-
2:30
impassion130: immunotherapy for tnbc
-
13:53
immune checkpoint inhibitors & co-stimulatory molecules | presented by dr. philippe bedard
-
1:39
encouraging developments in triple negative breast cancer immunotherapy